Ping An Healthcare and Technology Company (1833) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
15 May, 2026Executive summary
Achieved first full-year profitability in 2024 with net profit of RMB88.3 million, marking a historic milestone and reflecting improved operational efficiency and business model maturity.
Total revenue grew 2.9% year-on-year to RMB4,808.1 million, driven by strong B-end (corporate) and F-end (integrated finance/individual) business growth.
Senior care services revenue surged 413.5% year-on-year, unlocking new business potential and expanding to 75 cities.
Strategic focus on AI empowerment, multi-scenario service delivery, and integration with Ping An Group for synergistic growth.
Special dividend of HK$9.7 per share distributed, with Ping An Group opting for scrip dividend, resulting in formal consolidation into Ping An Group.
Financial highlights
Revenue: RMB4,808.1 million, up 2.9% year-on-year; gross profit: RMB1,523.4 million, up 1.0%; gross margin: 31.7%.
Net profit: RMB88.3 million (2023: loss of RMB334.9 million); adjusted net profit: RMB158.5 million.
Operating cash flows turned positive at ~RMB99 million.
Senior care revenue rose to RMB282.8 million, up 413.5% year-on-year; B-end business revenue grew 32.7%.
Administrative expenses fell 37.2% year-on-year to RMB930.0 million; selling and marketing expenses down 8.6% to RMB763.5 million.
Outlook and guidance
Continued investment in AI, digital operations, and scenario-based service expansion planned for 2025.
Focus on high-margin businesses such as health checkups and home-based senior care to drive future profitability.
Enhanced synergies with Ping An Group to support customer acquisition and retention, leveraging favorable policies and market opportunities in aging society.
Latest events from Ping An Healthcare and Technology Company
- Q1 2026 revenue up 9.1% and adjusted net profit up 45.8%, driven by health and AI growth.1833
Q1 202623 Apr 2026 - Revenue and adjusted net profit surged, led by corporate health management and efficiency gains.1833
H2 202525 Mar 2026 - Net profit surged 136.8% on 19.5% revenue growth, driven by AI, margin gains, and a special dividend.1833
H1 20256 Jan 2026 - Returned to profit in H1 2024, driven by cost control and rapid growth in strategic segments.1833
Q2 20242 Dec 2025 - Revenue and profit surged, driven by corporate health and AI-enabled service expansion.1833
Q3 202523 Oct 2025 - Q1 2025 saw robust revenue and profit growth, fueled by healthcare-insurance synergy and AI innovation.1833
Q1 20256 Jun 2025